Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00281853 · ClinicalTrials.gov registry record
Nerve Changes in Patients Who Are Undergoing Chemotherapy or Biological Therapy for Cancer
A clinical trial, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- 15
- Enrollment target
NCT00281853: Completed study, sponsored by Case Comprehensive Cancer Center.
NCT00281853 is a clinical trial that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00281853 has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
Study Summary
RATIONALE: Learning about the effects of chemotherapy and biological therapy on nerve function may help doctors plan treatment and help patients live more comfortably. PURPOSE: This clinical trial is studying peripheral neuropathy in patients who are receiving chemotherapy or biological therapy for cancer.
Interventions
- PROCEDURE management of therapy complications
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2005-03 |
| Est. Completion | 2007-08 |
What the finished NCT00281853 record still lists
NCT00281853 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which management of therapy complications is the first listed.
NCT00281853 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00281853 about?
NCT00281853 is a clinical study titled "Nerve Changes in Patients Who Are Undergoing Chemotherapy or Biological Therapy for Cancer". RATIONALE: Learning about the effects of chemotherapy and biological therapy on nerve function may help doctors plan treatment and help patients live more comfortably. PURPOSE: This clinical trial is studying peripheral neuropathy in patients who are receiving chemotherapy or biological therapy for...
What is the current status of trial NCT00281853?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2005-03. Estimated completion is 2007-08.
What interventions are being tested in trial NCT00281853?
The interventions under investigation include: management of therapy complications (PROCEDURE).
Who is sponsoring clinical trial NCT00281853?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia